by Barbara Casolla, Univ. Lille, Inserm U1171, Degenerative & vascular cognitive disorders, CHU Lille, Department of Neurology, F-59000 Lille, France Clinical profile and therapeutic options for stroke patients have changed very fast during the last two decades and our practice has changed consequently, with more aggressive treatments for patients with severe neurological injury. Up to […]
Manoeuvre Count in Thrombectomy – Don’t Stop ‘Til You Get Enough? By Johannes Kaesmacher, MD, University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern For first- and second-generation devices it was very early shown that clinical outcome gets worse with each manoeuvre performed (i.e. device retrieval or contact aspiration attempt). Logically, manoeuvre count is […]
by Francesca Romana Pezzella and Hanne Krarup Christensen Alteplase has been added to the WHO Model List of Essential Medicines as a result of World Stroke Organization 30 stroke experts task-force who applied the WHO for including it in the Model List of Essential Medicines. Since 1977 World Health Organization (WHO) has been publishing every […]
The organisation of stroke services, evaluation of stroke outcomes, assessment of quality of care pathways and life after stroke are central domains targeted by the European Stroke Action Plan 2018-2030.
To qualify as an FESO, members must demonstrate scientific quality and a willingness to actively volunteer in ESO. There are no age requirements, but FESO must meet minimum standards. FESO receive additional benefits, including participation in the Council of Fellows. Visit our website for more information on how to distinguish yourself as a FESO. We […]
ESJ Comment: Young ischaemic stroke incidence and demographic characteristics – The Norwegian stroke in the young study – A three-generation research program. Author: Dr Nicolas Martinez-Majander, Department of Neurology, Helsinki University Hospital, Finland. Original Article: Nawaz B, Eide GE, Fromm A et al, 2019. Young ischaemic stroke incidence and demographic characteristics – The Norwegian stroke […]
European Stroke Organisation Department to Department Visit Program 2018- Visit Report Awardee: Mariana Dias Period of the visit: 1 January 2019 – 28 June 2019 During my 6 months stay at Vall d’Hebron University Hospital Stroke Unit I had the opportunity to experience and learn different areas and technics. I have spent 1 month on […]
Georgia Fisher, University of Technology Sydney, Sydney, AustraliaParticipant of the Young Stroke Physicians and Researchers Research Design Workshop for Studies in Development – ESOC 2019 The advent of clot busting medications and endovascular clot retrieval has revolutionised acute stroke management in recent years, resulting in large improvements in patient prognosis. This improved prognosis impacts all […]
By Dr Linxin LiMiss A is 30 years old. She has history of migraine with visual aura since her teenage years, which normally starts with blurred vision followed by a mild headache. She is otherwise fit and well. This morning she woke up feeling fine. However, whilst cycling to work, her vision became blurred. She […]